NASDAQ:MREO

Mereo Biopharma Group Stock Predictions

Healthcare > Biotechnology

Buy MREO

*Your capital is at risk

$0.334

-0.0052 (-1.53%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

MREO Prediction Chart

MREO Predictions History

Latest community submissions for MREO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Kent Hassell @KentHassell.272501	Oct 19, 2023	Bullish	$1.80	X	—	0
JS Pro	May 10, 2023	$1.20 +0.84%	$1.15	X	95.65%	0
PredictionBot.Kathy Pro	May 10, 2023	$1.23 +3.58%	$1.15	X	92.82%	0
PredictionBot.Warren Pro	May 10, 2023	$1.22 +2.24%	$1.15	X	94.21%	0
MacSteele13	Jan 10, 2023	Bullish	$0.86	X	—	0
JS Pro	Jul 13, 2022	$1.52 -1.94%	$1.54	V	98.70%	2
Babylon	Jun 3, 2020	Bullish	$1.96	X	—	1
JS Pro	Jun 3, 2020	$1.77 -9.69%	$1.96	X	90.31%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MREO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MEREO BIOPHARMA GROUP PLC

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by